Quick Answer
OCULAR THERAPEUTIX, INC reported Net Income of -$265.94 million for fiscal year 2025.
OCULAR THERAPEUTIX, INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$265.94M | -37.4% |
| 2024 | -$193.51M | -139.7% |
| 2023 | -$80.74M | -13.7% |
| 2022 | -$71.04M | -984.1% |
| 2021 | -$6.55M | +95.8% |
| 2020 | -$155.64M | -80.2% |
| 2019 | -$86.37M | -44.0% |
| 2018 | -$59.98M | +5.4% |
| 2017 | -$63.39M | -41.8% |
| 2016 | -$44.70M | -12.5% |
| 2015 | -$39.75M | -38.7% |
| 2014 | -$28.65M | -115.1% |
| 2013 | -$13.32M | +5.5% |
| 2012 | -$14.09M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$69.42M | -90.2% | -2.4% |
| June 30, 2025 | -$67.81M | -54.9% | -5.9% |
| March 31, 2025 | -$64.05M | +1.2% | -75.5% |
| September 30, 2024 | -$36.49M | -6972.3% | +16.6% |
| June 30, 2024 | -$43.78M | -111.7% | +32.5% |
| March 31, 2024 | -$64.85M | -113.9% | -12467.4% |
| September 30, 2023 | -$516.0K | +97.9% | +97.5% |
| June 30, 2023 | -$20.68M | -10.2% | +31.8% |
- OCULAR THERAPEUTIX, INC showed a decrease of -37.4% in Net Income compared to the prior fiscal year.
- Over the 2012–2025 period, OCULAR THERAPEUTIX, INC’s net income has declined by 1787.0% (from -$14.09 million to -$265.94 million).
- The most recent figure is from OCULAR THERAPEUTIX, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: